# LISATA THERAPEUTICS, INC. (LSTA) — tender_offer/third_party [expired]
Source: SEC API (secapi.ai) · situation sit_e94437e3204762cee992 · retrieved 2026-08-11T15:52:20.654Z

## Overview
Lisata Therapeutics, Inc. is a pharmaceutical company developing therapeutic treatments.

Kuva Acquisition Corp., a subsidiary of Kuva Labs Inc., launched a tender offer to purchase all outstanding common shares of Lisata Therapeutics at $4.00 per share in cash plus one contingent value right (CVR) representing the right to receive up to $3.00 per CVR in contingent cash payments upon achievement of specified milestones. The offer expired on July 20, 2026, with approximately 6,095,868 shares (66.8% of outstanding shares) validly tendered, satisfying the minimum tender condition. However, Parent informed the Company that it was unable to obtain sufficient financing to fund the offer as of the expiration time, and as of the filing date, Purchaser had not accepted for payment the tendered shares or confirmed a date by which it would do so.

## Terms
- Counterparty: Kuva Acquisition Corp. (subsidiary of Kuva Labs Inc.) · Consideration: mixed · Stake: 66.8% · Price/share: $4

## Key dates
- Expiry 2026-07-20 · Expired 2026-07-21

## Timeline
- 2026-07-21 · SC 14D9/A (0001140361-26-029022): SC 14D9/A - LISATA THERAPEUTICS, INC. — *Lisata Therapeutics, Inc. is a pharmaceutical company developing therapeutic treatments.* Kuva Acquisition Corp., a subsidiary of Kuva Labs Inc., launched a tender offer to purchase all outstanding common shares of Lisata Therapeutics at $4.00 per share in cash plus one contingent value right (CVR) representing the right to receive up to $3.00 per CVR in contingent cash payments upon achievement of specified milestones. The offer expired on July 20, 2026, with approximately 6,095,868 shares (66.8% of outstanding shares) validly tendered, satisfying the minimum tender condition. However, Parent informed the Company that it was unable to obtain sufficient financing to fund the offer as of the expiration time, and as of the filing date, Purchaser had not accepted for payment the tendered shares or confirmed a date by which it would do so.
  https://www.sec.gov/Archives/edgar/data/320017/0001140361-26-029022.txt

## Citations
- 0001140361-26-029022 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000114036126029022